Mammographic positioning is a critical yet often overlooked factor in breast density assessment, directly impacting cancer risk models (e.g., Tyrer-Cuzick v8) and clinical decisions. Poor positioning leads to misclassification of breast density categories (BI-RADS), skewing risk predictions and downstream care pathways.

Learn how to transform your mammography practice into a model of efficiency, continuous quality improvement, clinical excellence and sustainable growth that fosters patient trust. 

intelliRisk™ enables healthcare providers to assess, identify, and manage high risk patients efficiently and effectively. By incorporating established clinical guidelines, advanced short-term and long-term breast cancer risk models, and best practices, it supports informed decision-making across the entire breast health pathway.

    - Streamline breast cancer risk assessments 
    - Improve high-risk patient identification for personalized screening protocols 
    - Boost patient engagement and compliance 
    - Optimize follow-up care coordination 
    - Enable scalable high-risk program management

The Economics of High-Risk Clinics

Healthcare leaders across the spectrum – service line managers, CMOs, CIOs, large health systems, Integrated Delivery Network, and private radiology groups – are increasingly recognizing the pivotal role of high-risk breast cancer clinics. Once considered a niche concept, these specialized programs are quickly becoming a standard component of comprehensive breast care. The big question for administrators and executives is clear: How do high-risk clinics financially justify themselves while improving patient outcomes?